(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Quarter results tomorrow
(bmo 2024-04-28)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer...
Stats | |
---|---|
Today's Volume | 1.01M |
Average Volume | 708 110 |
Market Cap | 93.07M |
EPS | SEK0 ( 2024-02-21 ) |
Next earnings date | ( SEK0 ) 2024-04-28 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.200 |
ATR14 | SEK0.0300 (1.46%) |
Volume Correlation
Immunovia AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immunovia AB (publ) Correlation - Currency/Commodity
Immunovia AB (publ) Financials
Annual | 2023 |
Revenue: | SEK1.58M |
Gross Profit: | SEK-5.11M (-324.25 %) |
EPS: | SEK-7.95 |
FY | 2023 |
Revenue: | SEK1.58M |
Gross Profit: | SEK-5.11M (-324.25 %) |
EPS: | SEK-7.95 |
FY | 2022 |
Revenue: | SEK1.15M |
Gross Profit: | SEK-3.07M (-267.77 %) |
EPS: | SEK-5.95 |
FY | 2021 |
Revenue: | SEK844 000 |
Gross Profit: | SEK15.81M (1 873.58 %) |
EPS: | SEK-6.89 |
Financial Reports:
No articles found.
Immunovia AB (publ)
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators